These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


154 related items for PubMed ID: 15835479

  • 1. Gastroesophageal reflux and prokinetic agents.
    Hammer D.
    Neonatal Netw; 2005; 24(2):51-8; quiz 59-62. PubMed ID: 15835479
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Medical treatment of gastroesophageal reflux by prokinetic drugs].
    Coffin B.
    Gastroenterol Clin Biol; 1999 Jan; 23(1 Pt 2):S90-6. PubMed ID: 10078437
    [No Abstract] [Full Text] [Related]

  • 8. Gastric emptying in gastroesophageal reflux and the therapeutic role of prokinetic agents.
    McCallum RW.
    Gastroenterol Clin North Am; 1990 Sep; 19(3):551-64. PubMed ID: 1977702
    [Abstract] [Full Text] [Related]

  • 9. Effect of erythromycin on postprandial gastroesophageal reflux in reflux esophagitis.
    Pehl C, Pfeiffer A, Wendl B, Stellwag B, Kaess H.
    Dis Esophagus; 1997 Jan; 10(1):34-7. PubMed ID: 9079271
    [Abstract] [Full Text] [Related]

  • 10. Effects of metoclopramide and bethanechol on delayed gastric emptying present in gastroesophageal reflux patients.
    McCallum RW, Fink SM, Lerner E, Berkowitz DM.
    Gastroenterology; 1983 Jun; 84(6):1573-7. PubMed ID: 6132852
    [Abstract] [Full Text] [Related]

  • 11. Gastric emptying in the critically ill.
    Schuster-Bruce M.
    Crit Care Med; 2001 Jun; 29(6):1293-4. PubMed ID: 11395631
    [No Abstract] [Full Text] [Related]

  • 12. The current status of gastric prokinetic drugs.
    Schapira M, Henrion J, Heller FR.
    Acta Gastroenterol Belg; 1990 Jun; 53(4):446-57. PubMed ID: 1982914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic modulation of motility.
    McCallum RW.
    Yale J Biol Med; 1999 Jun; 72(2-3):173-80. PubMed ID: 10780579
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prokinetics in the treatment of gastro-oesophageal reflux disease. International symposium. Paris, France, 5 September 1996.
    Heading RC, Baldi F, Holloway RH, Janssens J, Jian R, McCallum RW, Richter JE, Scarpignato C, Sontag SJ, Wienbeck M.
    Eur J Gastroenterol Hepatol; 1998 Jan; 10(1):87-93. PubMed ID: 9512959
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks.
    Hawkyard CV, Koerner RJ.
    J Antimicrob Chemother; 2007 Mar; 59(3):347-58. PubMed ID: 17289772
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of metoclopramide and bethanechol on lower esophageal sphincter pressure in reflux patients.
    McCallum RW, Kline MM, Curry N, Sturdevant RA.
    Gastroenterology; 1975 May; 68(5 Pt 1):1114-8. PubMed ID: 1092585
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.